Top compounds associated with response to NTRK3


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.046 0.2
mRNA embelin GDSC1000 pan-cancer AAC -0.049 0.2
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA EX-527 GDSC1000 pan-cancer AAC 0.048 0.2
mRNA lovastatin CTRPv2 pan-cancer AAC -0.052 0.2
mRNA nintedanib CTRPv2 pan-cancer AAC 0.053 0.2
mRNA BMS-708163 GDSC1000 pan-cancer AAC 0.046 0.2
mRNA AC220 GDSC1000 pan-cancer AAC 0.048 0.2
mRNA SN-38 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
Download CSV